Natixis Abbott Laboratories Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Abbott Laboratories stock. As of the latest transaction made, Natixis holds 409,539 shares of ABT stock, worth $48.2 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

409,539

Previous 522,045 21.55%

Holding current value

$48.2 Million

Previous $54.2 Million 13.93%

% of portfolio

0.27%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $11.3 Million - $13.3 Million	-112,506 Reduced 21.55%	409,539 $46.7 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $31.2 Million - $34.8 Million	309,879 Added 146.05%	522,045 $54.2 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $37.8 Million - $41.7 Million	-345,085 Reduced 61.93%	212,166 $24.1 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $5.18 Million - $6.33 Million	-57,381 Reduced 9.34%	557,251 $61.3 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $11 Million - $13.2 Million	-115,016 Reduced 15.76%	614,632 $59.5 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $30.5 Million - $34 Million	303,070 Added 71.05%	729,648 $79.5 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $21.4 Million - $25.2 Million	221,151 Added 107.65%	426,578 $43.2 Million
Q4 2022 Feb 24, 2023	SELL	$95.06 - $111.52 $16.4 Million - $19.3 Million	-173,032 Reduced 45.72%	205,427 $22.6 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $5.83 Million - $6.84 Million	61,339 Added 19.34%	378,459 $41.6 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $9.93 Million - $11.5 Million	102,676 Added 47.88%	317,120 $30.9 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $64.5 Million - $78 Million	-631,967 Reduced 74.66%	214,444 $23.2 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $87.9 Million - $107 Million	771,111 Added 1024.05%	846,411 $100 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $68.4 Million - $83.7 Million	-591,821 Reduced 88.71%	75,300 $10.6 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $11 Million - $12.2 Million	-94,496 Reduced 12.41%	667,121 $78.8 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $35.9 Million - $42.3 Million	339,574 Added 80.46%	761,617 $88.3 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $4.74 Million - $5.59 Million	43,589 Added 11.52%	422,043 $50.6 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $39.7 Million - $43.3 Million	378,454 New	378,454 $41.4 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $7.42 Million - $9.01 Million	-80,955 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $73.5 Million - $94.1 Million	-959,712 Reduced 92.22%	80,955 $7.4 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $65.4 Million - $95.6 Million	1,040,667 New	1,040,667 $82.1 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $44.9 Million - $50 Million	-571,551 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $46.8 Million - $50.7 Million	571,551 New	571,551 $47.8 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $5.03 Million - $6.07 Million	-82,783 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $28.1 Million - $31 Million	-487,723 Reduced 85.49%	82,783 $5.03 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $4.53 Million - $5.12 Million	-80,470 Reduced 12.36%	570,506 $34 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $34.3 Million - $36.8 Million	639,607 Added 5625.89%	650,976 $37.2 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $546,394 - $609,833	11,369	11,369 $607,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account